Search for content and authors
 

ANTIMICROBIAL ACTIVITIES OF 4-SUBSTITUTED 3-(PIPERIDIN-4-YL)-Δ2-1,2,4-TRIAZOLINE - 5 - THIONES

Maria Dobosz 1Agata Siwek 1Urszula Kosikowska 2

1. Medical University, Faculty of Pharmacy, Department of Organic Chemistry, Staszica 6, Lublin 20-081, Poland
2. Medical University, Faculty of Pharmacy, Department of Pharmaceutical Microbiology, Chodźki 1, Lublin 20-093, Poland

Abstract

The cyclization reaction of 4-substituted 1-[(piperidin-4-yl)-carbonyl]thiosemicarbazides 1 gave 4-substituted 3-(piperidin-4-yl)-Δ2-1,2,4-triazoline-5-thiones 2.

piperydyna_1_1.gif

Cyclic compounds 2 with R = C6H5, 4-BrC6H5, 4-I-C6H5 were screened for their antimicrobial activity in vitro against 14 species of aerobic bacteria and 12 species of fungi. MIC (Minimal Inhibitory Concentration) values defined as the lowest concentration of compounds required to inhibit the visible growth of the tested microorganism, was estimated by agar-dilution method. Petri dishes containing Mueller-Hinton agar (for bacteria) or RPMI 1640 agar (for fungi) and the compounds at a concentration of 31.25-500 mg/mL were inoculated with a culture size no. 0.5 McFarland Standards and incubated at 37 oC for 18 h for bacteria and at 30 oC for 5 days for fungi. The growth of microorganisms were compared with a control culture without the tested compounds. The compounds 2 with R = C6H5 and R = 4-I-C6H5 were not active against bacteria, however, compound 2 with R = 4-BrC6H5 partially inhibited the growth of Staphylococcus sp. species (by about 80-95%) with values ranging from 125-500 mg/mL. All compounds were active against Trichophyton sp. with MIC values of 62.5-500 mg/mL, depending on the species. The tested compounds had not activity against yeast-like fungi and moulds. Only compound 2, R = 4-BrC6H5 affected the growth of Aspergillus niger with MIC value of 62.5 mg/mL.

 

Legal notice
  • Legal notice:
 

Related papers

Presentation: Poster at V Multidyscyplinarna Konferencja Nauki o Leku, by Agata Siwek
See On-line Journal of V Multidyscyplinarna Konferencja Nauki o Leku

Submitted: 2006-02-03 07:55
Revised:   2009-06-07 00:44